4'-Fluor-3,4-methylendioxy-chalkon | 7397-23-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 4'-Fluor-3,4-methylendioxy-chalkon
• 英文别名: 3-benzo[1,3]dioxol-5-yl-1-(4-fluoro-phenyl)-propenone；3-(1,3-benzodioxol-5-yl)-1-(4-fluorophenyl)prop-2-en-1-one
• CAS: 7397-23-1
• 化学式: C₁₆H₁₁FO₃
• 分子量: 270.26
• InChiKey: HDSDUHZGXYSYKW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2932999099

反应信息

• 作为反应物：
  描述：

  4'-Fluor-3,4-methylendioxy-chalkon 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 4.0h， 生成
  参考文献：
  名称：

  Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors

  摘要：

  A series of novel pyrazoline-containing derivatives (15-47) has been designed, synthesized and evaluated for their biological activities. Among them, compound 18 displayed the most potent antiproliferative activity against A549, MCF-7 and HepG-2 cells line (IC50 = 0.07 mu M, 0.05 mu M, 0.03 mu M, respectively) and the tubulin polymerization inhibitory activity (IC50 = 1.88 mu M), being comparable to CA-4. Furthermore, we also tested that compound 18 was a potent inducer of apoptosis in HepG-2 cells and it had cellular effects typical for microtubule interacting agents, causing accumulation of cells in the G2/M phase of the cell cycle. These studies, along with molecular docking, provided a new molecular scaffold for the further development of antitumor agents that target tubulin. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.02.058
• 作为产物：
  描述：

  3-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-1-(4-methoxy-phenyl)-propenone 在 potassium carbonate 、 potassium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 20.0h， 生成 4'-Fluor-3,4-methylendioxy-chalkon
  参考文献：
  名称：

  以苯并二恶唑为潜在抗癌剂的噻唑基-吡唑啉衍生物的合成，分子对接和评价

  摘要：

  已经设计并合成了一系列含有苯并二恶唑（C1-C20）的新型噻唑基-吡唑啉衍生物。在合成的化合物中，2-（5-（苯并[ d ] [1,3]二恶酚-5-基）-3-（4-溴苯基）-4,5-二氢-1 H-吡唑-1-基）-4-（4-溴苯基）噻唑（C6）对HER-2表现出最强的抑制活性（HER-2的IC 50  = 0.18μM）。抗增殖试验结果表明，化合物C6在体外对MCF-7和B16-F10具有很高的抗增殖活性，IC 50值分别为0.09和0.12μM，与阳性对照厄洛替尼相当。进一步进行对接仿真以确定可能的结合模型。根据初步结果，在肿瘤生长中具有强抑制活性的化合物C6将是潜在的抗癌药。

  DOI：

  10.1016/j.bmc.2012.11.020

文献信息

• A Novel Series of 3,4-Disubstituted Dihydropyrazoles: Synthesis and Evaluation for MAO Enzyme Inhibition
  作者：Maria Cristina Cardia、Maria Luisa Sanna、Rita Meleddu、Simona Distinto、Matilde Yañez、Dolores Viña、Manuel Lamela、Elias Maccioni

  DOI：10.1002/jhet.1072

  日期：2013.2

  In this study, the authors have designed and synthesized a novel series of 3-acyl-4-aryl-4,5-dihydropyrazoles, with the aim to obtain new potential scaffolds for the inhibition of both isoforms of monoamine oxidase (MAO) enzyme. The synthetic pathway to these compounds includes as a key step the 1,3-dipolar cycloaddition reaction of diazomethane with a chalcone. All the compounds were fully characterized

  在这项研究中，作者设计并合成了一系列新的3-酰基-4-芳基-4,5-二氢吡唑类化合物，目的是获得新的抑制单胺氧化酶（MAO）两种同工型的潜在支架。这些化合物的合成途径包括关键步骤：重氮甲烷与1,3-偶极甲烷的1,3-偶极环加成反应。查尔酮。所有化合物均通过光谱和分析数据充分表征，并显示出对MAO A的特异性抑制作用。
• 4,5-Dihydropyrazole derivatives containing oxygen-bearing heterocycles as potential telomerase inhibitors with anticancer activity
  作者：Yin Luo、Yang Zhou、Jie Fu、Hai-Liang Zhu

  DOI：10.1039/c4ra02200a

  日期：——

  Telomere and telomerase were closely related to the occurrence and development of some cancers. After the key active site of telomerase was identified, to enhance the ability of dihydropyrazole derivatives to inhibit telomerase, we designed a series of novel 4,5-dihydropyrazole derivatives containing heterocyclic oxygen moiety based on previous studies. The telomerase inhibition assay showed that compound 10a displayed the most potent inhibitory activity with an IC50 value of 0.6 μM for telomerase. The antiproliferative assay showed that 10a exhibited high activity against human gastric cancer cell SGC-7901 with an IC50 value of 10.95 ± 0.60 μM. Flow cytometric analysis and western blot results showed that 10a induced both apoptosis and autophagy. A docking simulation showed that 10a could bind well to the active site of telomerase and act as a telomerase inhibitor. The 3D-QSAR model was also built to provide a more pharmacological understanding that could be used to design new agents with more potent telomerase inhibitory activity.

  端粒和端粒酶与某些癌症的发生发展密切相关。在鉴定出端粒酶关键活性部位后，基于以往的研究，为了增强二氢吡唑衍生物抑制端粒酶的能力，我们设计了一系列含有杂环氧基的新型4,5-二氢吡唑衍生物。端粒酶抑制实验表明，化合物10a显示出最强的抑制活性，其对端粒酶的IC50值为0.6 μM。细胞增殖实验表明，10a对胃癌细胞SGC-7901具有很高的活性，其IC50值为10.95 ± 0.60 μM。流式细胞分析和western blot结果显示，10a可诱导细胞凋亡和自噬。对接模拟显示，10a可与端粒酶的活性位点很好地结合，并作为端粒酶抑制剂发挥作用。同时，为了能更好地指导设计出新的具有更强端粒酶抑制活性的化合物，我们构建了三维定量构效关系(3D-QSAR)模型。
• Synthesis of 1-Substituted 3-Aryl-5-aryl(hetaryl)-2-pyrazolines and Study of Their Antitumor Activity
  作者：Braulio Insuasty、Leidy Chamizo、Jhon Muñoz、Alexis Tigreros、Jairo Quiroga、Rodrigo Abonía、Manuel Nogueras、Justo Cobo

  DOI：10.1002/ardp.201100170

  日期：2012.4

  Three series of novel 1,3,5‐trisubstituted 2‐pyrazoline derivatives containing thiophene and benzodioxol moieties as potential antitumor agents were synthesized. The in vitro antitumor activity of the obtained compounds was determined at the National Cancer Institute (NCI). The 5‐(benzo[d][1,3]dioxol‐5‐yl)‐3‐(4‐methoxyphenyl)‐4,5‐dihydro‐1H‐pyrazole‐1‐carbothioamide (9a) is the most prominent of the

  合成了三个系列的新型 1,3,5-三取代 2-吡唑啉衍生物，其中含有噻吩和苯并二氧杂环戊烷作为潜在的抗肿瘤剂。获得的化合物的体外抗肿瘤活性在美国国家癌症研究所 (NCI) 进行了测定。5-(benzo[d][1,3]dioxol-5-yl)-3-(4-甲氧基苯基)-4,5-dihydro-1H-pyrazole-1-carbothioamide (9a) 是最突出的由于其对白血病 (RPMI-8226)、肾癌 (UO-31) 和前列腺癌 (DU-145) 细胞系具有显着的活性，GI50 值分别为 1.88、1.91 和 1.94 µM。
• An expedient, one-pot, stepwise sequential approach for the regioselective synthesis of pyrazolines
  作者：Suresh Ganesan、Muniraj Sarangapani、Mukesh Doble

  DOI：10.1177/1747519820977165

  日期：2021.3

  An efficient approach for the synthesis of pyrazoline/pyrazole-tethered pyridinyl methanones is described via a one-pot, stepwise, sequential methodology using chalcones and pyridine-4-carbohydrazi...

  通过使用查耳酮和吡啶-4-碳酰肼的单锅、逐步、顺序方法，描述了一种合成吡唑啉/吡唑系吡啶基甲酮的有效方法。
• Antimycobacterial Activity of Pyrimido[4,5-b]diazepine Derivatives
  作者：Braulio Insuasty、Angélica García、Juan Bueno、Jairo Quiroga、Rodrigo Abonia、Alejandro Ortiz

  DOI：10.1002/ardp.201100433

  日期：2012.9

  Three series of novel 8,9‐dihydro‐7H‐pyrimido[5,4‐b][1,4]diazepines, 4a–d, 5a–d, and 7a–d, were efficiently obtained in good yields using simple reaction methodologies. These pyrimidodiazepines were evaluated against 15 Mycobacterium spp. strains. Moderate activity in the inhibition of 13 microorganisms was obtained for the four compounds 4a, 5a, 5c, and 5d.

  使用简单的反应方法以良好的收率有效地获得了三个系列的新型 8,9-二氢-7H-嘧啶并[5,4-b][1,4]二氮杂类，4a-d、5a-d 和 7a-d . 这些嘧啶二氮卓类药物针对 15 种分枝杆菌进行了评估。菌株。四种化合物 4a、5a、5c 和 5d 在抑制 13 种微生物中获得了中等活性。